(Q54091788)

24 May 2018

title

High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma (English)

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

1 February 2023

1 reference

1 reference

1 reference

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

1 February 2023

author name string

Beattie EJ Jr

6

1 reference

24 May 2018

G. Rosen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4544836

1 February 2023

S. Suwansirikul

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4544836

1 February 2023

C. Kwon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4544836

1 February 2023

C. Tan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4544836

1 February 2023

S. J. Wu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4544836

1 February 2023

E. J. Beattie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4544836

1 February 2023

M. L. Murphy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4544836

1 February 2023

language of work or name

English

0 references

publication date

1 April 1974

1 reference

24 May 2018

full work available at URL

number of pages

13

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

1 February 2023

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

1 February 2023

1 reference

24 May 2018

volume

33

1 reference

24 May 2018

issue

4

1 reference

24 May 2018

page(s)

1151-1163

1 reference

24 May 2018

Integrated therapy for Ewing's sarcoma.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197404%2933%3A4%3C1151%3A%3AAID-CNCR2820330439%3E3.0.CO%3B2-8

Massive preoperative radiation therapy in the treatment of osteogenic sarcoma

21 January 2018

1

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Doxorubicin in disseminated osteosarcoma

1 February 2023

2

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Evaluation of a high dose cyclophosphamide regimen in childhood tumors.

1 February 2023

9

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

The therapy of osteogenic sarcoma: Current status and thoughts for the future

1 February 2023

11

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion pattern

1 February 2023

13

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

1 February 2023

14

32

1506

Hryniuk

1972

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Treatment of clinically localized Ewing's sarcoma with radiotherapy and combination chemotherapy

1 February 2023

15

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Recent advances in the chemotherapy of metastatic osteogenic sarcoma

1 February 2023

16

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy

1 February 2023

17

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Osteosarcoma.An assessment of management with particular reference to primary irradiation and selective delayed amputation

1 February 2023

18

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

OSTEOSARCOMA. A STUDY OF THE VALUE OF PREOPERATIVE MEGAVOLTAGE RADIOTHERAPY

1 February 2023

20

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

A clinicopathologic analysis of adriamycin cardiotoxicity

1 February 2023

21

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Osteosarcoma. A review of 96 cases

1 February 2023

22

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Multiple pulmonary resections in the treatment of osteogenic sarcoma

1 February 2023

25

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Effective absorption and utilization of oral formyltetrahydrofolate in man

1 February 2023

27

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Cyclophosphamide in children with cancer

1 February 2023

28

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Proceedings: Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy

1 February 2023

29

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

L-PHENYLALANINE MUSTARD AS A TREATMENT FOR METASTATIC OSTEOGENIC SARCOMA IN CHILDREN

1 February 2023

30

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Bone Sarcoma: Treatment by Irradiation, Amputation, or a Combination of the Two

1 February 2023

32

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases

1 February 2023

33

1 reference

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

https://api.crossref.org/works/10.1002/1097-0142(197404)33:4%3C1151::AID-CNCR2820330439%3E3.0.CO;2-8

1 February 2023

Identifiers

10.1002/1097-0142(197404)33:4<1151::AID-CNCR2820330439>3.0.CO;2-8

1 reference

24 May 2018

1 reference

24 May 2018